Archives: Speakers

I’m in the compressed air industry for 29 years, and at AF compressors for 19 years.
Always focus on energy saving and energy efficiency.

Dr. Forte Soto is an MHRA-accredited Principal Investigator with over 25 years of experience in clinical practice and research. As Director of Safety Human Pharmacology at Parexel’s London Early Phase Clinical Unit, he has led or contributed to more than 200 Phase I/II studies, including first-in-human trials, drug-drug interaction studies, bioequivalence, thorough QT, biosimilars, and proof-of-concept research.

His therapeutic expertise spans CNS, immunology, cardiovascular, metabolism, respiratory, and dermatology. Dr. Forte Soto holds a medical degree from the University of Central Venezuela, an MSc in Clinical Pharmacology from the University of Aberdeen, and a DPhil in Clinical Pharmacology from the University of London. He completed postdoctoral training at the William Harvey Research Institute and is a Fellow of the Faculty of Pharmaceutical Medicine (FFPM).

Jose Garcia is a Growth Director at Ai Palette, focused on enabling CPG companies to accelerate innovation through data-driven, AI-powered solutions. With a strong passion for helping brands succeed in an increasingly dynamic consumer landscape, he works with leading CPG companies to modernise how they identify opportunities, develop products, and bring innovations to market.

With a strong track record of driving impact across global brands, Jose has supported organisations in transforming their innovation and go-to-market capabilities at scale. At Ai Palette, he is responsible for building and sustaining strategic relationships with many of the largest players across the CPG space, such as Diageo, Mondelez, Suntory, and Nestlé, ensuring they continuously derive value from AI-led consumer insights and remain competitive in a fast-evolving market.

JJ Delgado is a digital strategy and innovation leader, currently serving as General Manager of MOVE (Hijos de Rivera / Estrella Galicia), where he drives new business models across eCommerce, AI, and at-home consumption. He has led global initiatives at companies such as Amazon, including the largest international sales day in the company’s history. A cum laude PhD in digital economy and member of the Royal European Academy of Doctors, he combines strategic vision, technology, and consumer psychology to help companies and leaders become truly irreplaceable in the age of artificial intelligence.

26 years of experience in conducting and leading global Phase II-IV studies in different therapeutic areas with the past 5+ years in Oncology space and working with small to medium sized Biotech’s in leading studies in Phase-I / FIH. Extensive experience in driving study deliveries, third party vendor management, portfolio level partnerships, and people management.

Conor Barry, Ph.D., is the Global Head of Bioconjugate Development at Piramal Pharma Solutions and a valued member of The Science Collective. In his role, Conor oversees our work in antibody-drug conjugates (ADCs), including processing and analytical development of bioconjugates, project scoping, and troubleshooting.

Prior to joining Piramal he held senior positions within AstraZeneca, leading ADC Analytical Sciences, and serving on the ADC pipeline leadership team. In this role he helped define the strategy and priorities for ADC development and CMC activities. Previously he worked as a Research Fellow in bioconjugation at Oxford University. Throughout his 19-year career, Conor has amassed an exceptional bioconjugate research and development track record, evidenced by his 23 peer-reviewed scientific publications.

While at Piramal Pharma Solutions, his innovative approach contributed to creating ADCelerate, a solution for antibody-drug conjugate drug development that accelerates timelines for developing the initial clinical supply of both drug substance and drug product. As Piramal’s scientific and technical lead on bioconjugates, Conor is well equipped to provide subject matter expertise for our clients.

Conor holds a Ph.D. in Organic Chemistry (Bristol), a PG Diploma in Strategy and Innovation (Oxford).

M.A. degreefor Philology

Qualified marketing expert (CCI)

Freudenberg Group

Business Administration

Product Manager Vileda

Marketing Manager Elefanten Schuh

Since 2000 in beer industry at König Ludwig International, a Trademark Holding for Royal Bavarian Beer Brands.

Heading the new division set up for commercializing the trademarks in a licensepartnership model in international markets.

Focus on new markets, international marketing, brand steering and brand management.